Captor Therapeutics Spolka Akcyjna (CTX.WA)

PLN 32.2

(1.58%)

Total Liabilities Summary of Captor Therapeutics Spolka Akcyjna

  • Captor Therapeutics Spolka Akcyjna's latest annual total liabilities in 2023 was 28.07 Million PLN , up 68.33% from previous year.
  • Captor Therapeutics Spolka Akcyjna's latest quarterly total liabilities in 2024 Q2 was 26.96 Million PLN , up 13.57% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported annual total liabilities of 16.67 Million PLN in 2022, down -13.76% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported annual total liabilities of 19.34 Million PLN in 2021, down -27.79% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported quarterly total liabilities of 23.74 Million PLN for 2024 Q1, down -15.42% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported quarterly total liabilities of 31.71 Million PLN for 2023 Q3, up 39.41% from previous quarter.

Annual Total Liabilities Chart of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Historical Annual Total Liabilities of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 28.07 Million PLN 68.33%
2022 16.67 Million PLN -13.76%
2021 19.34 Million PLN -27.79%
2020 26.78 Million PLN 27.42%
2019 21.02 Million PLN 43.68%
2018 14.63 Million PLN 193.78%
2017 4.98 Million PLN 0.0%

Peer Total Liabilities Comparison of Captor Therapeutics Spolka Akcyjna

Name Total Liabilities Total Liabilities Difference
Bioceltix S.A. 2.26 Million PLN -1137.516%
BIOTON S.A. 215.86 Million PLN 86.995%
Mabion S.A. 90.47 Million PLN 68.971%
Molecure S.A. 11.34 Million PLN -147.464%
NanoGroup S.A. 1.49 Million PLN -1784.038%
Pharmena S.A. 1.9 Million PLN -1372.928%
Poltreg S.A. 39.58 Million PLN 29.072%
Pure Biologics Spólka Akcyjna 20.84 Million PLN -34.68%
Ryvu Therapeutics S.A. 120.36 Million PLN 76.675%
Synthaverse S.A. 153.26 Million PLN 81.683%
Urteste S.A. 1.85 Million PLN -1413.423%